Statin Therapy

Use of statin therapy within the first year after breast cancer diagnosis appeared associated with a survival benefit among women with stage I to stage III triple-negative breast cancer, according to study results published in Cancer.

Recent data presented at the European Society of Cardiology Congress revealed that people who drank up to 3 cups of coffee daily had a lower risk for death and incident stroke than non-coffee drinkers.

A web application to help individuals self-prescribe statin therapy demonstrated 96% agreement with subsequent physician judgment, according to research published in the Journal of the American College of Cardiology.

About 25% of U.S. adults have nonalcoholic fatty liver disease, which is the most common chronic liver condition in the U.S., according to the American Liver Foundation.

This month’s cover story puts forth a call to action for our fellow physicians to be more aware of fatty liver disease risk. But this call needs to be about more than awareness. It must be a call for multidisciplinary coordinated screening and follow-up.

The FDA is requesting that manufacturers of statins remove its strongest warning from current prescribing information, which states that these medications should never be used during pregnancy.

Atorvastatin vs. placebo to prevent death and thrombosis in patients COVID-19 in the ICU.

The presence of coronary artery calcium among individuals with risk-enhancing factors was associated with increased atherosclerotic CVD events, exceeding the threshold for statin therapy initiation, researchers reported.

Individuals with heart disease or high blood pressure may be less likely to die from the COVID-19 virus if they use statins, according to findings published in PLOS ONE.

A new meta-analysis discussed how eicosapentaenoic acid monotherapy, compared with eicosapentaenoic acid plus docosahexaenoic acid, provided the greatest reduction in cardiovascular risk.